This brand name is authorized in France
The drug EXACOR contains one active pharmaceutical ingredient (API):
|
1
Cibenzoline
UNII 38G16RWJ37 - CIFENLINE SUCCINATE
|
|
Cibenzoline is a class I sodium channel blocker antiarrhythmic drug. Cibenzoline also has moderate calcium channel blocking (class IV) effects and prolongs the action potential duration through its potassium channel blocking (class III) effect. It is used for the treatment of supraventricular and ventricular arrhythmias, and in obstructive hypertrophic cardiomyopathy. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C01BG07 | Cibenzoline | C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BG Other class I antiarrhythmics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 66576865 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
